Adherence to antiretroviral therapy in HIV patients with psychiatric comorbidity [4]

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 5, 2004, Pages 1109-1110

  De Socio, Giuseppe Vittorio Luigi ^a   Fanelli, Luca ^b   Longo, Alessandro ^b   Stagni, Giuliano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ICOS Perugia ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SOCIOECONOMICS;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; ITALY; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; RESIDENTIAL FACILITIES;

EID: 3342898100     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200408150-00018     Document Type: Letter

References (10)

1. Gray R, Brewin E, Noak J, et al. A review of the literature on HIV infection and schizophrenia: implications for research, policy and clinical practice. J Psychiatr Ment Health Nurs. 2002;9:405-409.
2. Stephenson J, Woods S, Scott B, et al. HIV-related brain impairment from palliative care to rehabilitation. Int J Palliat Nurs. 2000;6:6-11.
3. Sternhell PS, Corr MJ. Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Aust N Z J Psychiatry 2002;36:528-533.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
5. Epi Info [computer program]. Version 6.0. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
6. Treisman GJ, Angelino AF, Hutton HE. Psychiatric issues in the management of patients with HIV infection. JAMA. 2001;286:2857-2864.
7. Palmer NB, Salcedo J, Miller AL, et al. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. Aids Patient Care STDS. 2003;17:635-644.
8. Wohl DA, Stephenson BL, Golin CE, et al. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis. 2003;36:1572-1576.
9. Murri R, Fantoni M, Del Borgo C, et al. Determinants of health-related quality of life in HIV-infected patients. AIDS Care. 2003;15:581-590.
10. Starace F, Ammassari A, Trotta MP, et al. AdICoNA Study Group. NeuroICoNA Study Group. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:5136-5139.